Back

Native T1 fails to predict outcome in attr amyloidosis but ecv does

26 May 2017 (18:00 - 18:10)
Organised by:
Congress Presentation Part of: Oral abstract session 3 Cardiac Magnetic Resonance EACVI Premium Access EuroCMR 2017

About the speaker

Photo
Doctor Karl Norrington

London (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
CMR tissue characterization indexes early and late after cardiac transplantation
Doctor P. Pedrotti (Milan, IT)
Slides
Presentation thumbnail
Multiparametric mapping identifies diffuse myocardial involvement in systemic sclerosis beyond conventional late gadolinium enhancement: a 100 patient prospective study
Doctor K. Norrington (London, GB)
Slides
Presentation thumbnail
Early detection of cardiac involvement in systemic sclerosis: the added value of magnetic resonance imaging
Assistant Professor A. Pepe (Pisa, IT)
Slides
Presentation thumbnail
Comparison betweenLGE-CMR and histomorphometric quantification of myocardial fibrosis in transplanted hearts for end-stage hypertrophic cardiomyopathy (hcm)
Doctor G. Galati (Milan, IT)
Slides
Presentation thumbnail
Left atrial blood flow, left ventricular diastolic function and interstitial fibrosis in hypertrophic cardiomyopathy: a combined t1-mapping, 4d-flow cmr and doppler echocardiography study
Doctor C. Contaldi (Naples, IT)
Slides

Access the full session

Session thumbnail
Oral abstract session 3

The Event

Event poster

EuroCMR 2017

26 May 2017 18:00 CET
You may be interested in
thumbnail
Congress Presentation
Tracking treatment response in cardiac AL amyloidosis with native-T1 mapping
10 May 2023
thumbnail
Congress Presentation
Utility of amily score for transthyretin amyloidosis patients in daily practice: easy and simple
29 June 2021
thumbnail
Congress Presentation
Multi-imaging characterisation of cardiac phenotype in different types of amyloidosis
29 August 2022
thumbnail
Congress Presentation
Abnormal right ventricular strain predicts poor prognosis in transthyretin amyloidosis
12 December 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources